Details of the Drug
General Information of Drug (ID: DML7Z1H)
Drug Name |
ACVR2B
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms | ACVR2B program (muscle atrophy); ACVR2B program (muscle atrophy), Rigel Pharmaceuticals; Activin type IIB receptorantagonist, (small molecule therapeutic, muscle atrophy), Rigel Pharmaceuticals | ||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||